Prevalence and Variables Associated With Depression in Subjects With Chronic Wounds Using PHQ-9 as a Screening Tool
1 other identifier
observational
150
1 country
1
Brief Summary
The objective of the study is to complete a retrospective chart review of subjects who were treated at the Wound Care Clinic at Methodist Dallas Medical Center, presented for treatment between June 2018 and February 2019, and were administered the PHQ-9. The study aims to measure the prevalence of depression in this sample, feasibility of using PHQ-9 in this patient population, and identifying variables and functional impairment associated with clinically significant depression.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Oct 2019
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 28, 2019
CompletedFirst Submitted
Initial submission to the registry
November 4, 2019
CompletedFirst Posted
Study publicly available on registry
January 8, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 14, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
November 14, 2022
CompletedFebruary 4, 2022
February 1, 2022
3 years
November 4, 2019
February 3, 2022
Conditions
Outcome Measures
Primary Outcomes (1)
PHQ-9 score
to measure the prevalence of clinically significant depression defined as a PHQ-9 score of equal to or greater than 10.
Through study completion, an average of 1 year
Eligibility Criteria
new patients who presented to the Wound Care Center at Methodist Dallas Medical Center between June 2018 and February 2019.
You may qualify if:
- Age 18 or older
- Received care at the Wound Care Center at Methodist Dallas Medical Center between June 2018 and February 2019
- Completed a PHQ-9 form at the time of initial evaluation/examination
You may not qualify if:
- \. Patients less than 18 years of age will be excluded from the study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Wound care & Hyperbaric Clinic
Dallas, Texas, 75203, United States
MeSH Terms
Conditions
Study Officials
- PRINCIPAL INVESTIGATOR
Asma Khatoon, MD
The Methodist Hospital Research Institute
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 4, 2019
First Posted
January 8, 2021
Study Start
October 28, 2019
Primary Completion
November 14, 2022
Study Completion
November 14, 2022
Last Updated
February 4, 2022
Record last verified: 2022-02